- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 3rd, 2006
A new report warns that as nanotechnology becomes a reality, Europe must not miss the boat, and raises the alarm that the potential benefits of nanomedicine in Europe will be lost without major investment in R&D.
The report, the result of a two-year-long study conducted by the European Science Foundation (ESF), concludes that emerging nanomedicine technologies will increasingly serve as new medical tools for diagnostics and therapeutics in various areas of healthcare including drug discovery and development, drug delivery and providing targeted therapy.
|Related News Press|
Nanometrics Announces Upcoming Investor Events July 28th, 2015
European Technology Platform for Nanomedicine and ENATRANS European Consortium Launch the 2nd edition of the Nanomedicine Award: The Award to be presented at BIO-Europe conference in Munich, November 2015 July 30th, 2015
Take a trip through the brain July 30th, 2015
Sol-gel capacitor dielectric offers record-high energy storage July 30th, 2015